A Multi‐mechanistic Drug Release Approach in a Bead Dosage Form and In Vivo Predictions

References

• Liu Y., Schwartz J. B., Schnaare R. L. A multi‐mechanistic drug release approach in a bead dosage form and in vitro predictions. Pharmaceutical Development and Technology 2003; 8(2)163–173
   PubMed Web of Science ®Google Scholar
• Chang S., Robinson J. R. H. A. Lieberman, L. Lachman, J. B. SchwartzSustained drug release from tablets and particles. Pharmaceutical Dosage Forms: Tablets, . Marcel Dekker, Inc., New York 1989; Vol. 3: 243
   Google Scholar
• Blythe R. H. The formulation and evaluation of sustained release products. Drug Standards 1958; 26(1)1–7
   Google Scholar
• Swintosky J. V. Design of oral sustained‐action dosage forms. Drug Cosmet. Ind. 1960; 87(4)464
   Google Scholar
• Gupta P. K., Robinson J. R. A. KydonieusOral controlled‐release delivery. Treatise on Controlled Drug Delivery, . Marcel Dekker, Inc., New York 1992, 255 pp.
   Google Scholar
• Bialer M., Kaplan S. A., Yacobi A. A. Yacobi, E. Halperin‐WalegaAnimal models in the primary screening of controlled release formulations. Oral Sustained Release Formulations: Design and Evaluation1st Ed., . Peagamon Press, New York 1988; 183–193
   Google Scholar
• Ogata H., Aoyagi N., Kaniwa N., Shibazaki T., Ejima A., Takagishi Y., Ogura T., Tomita K., Inoue S., Zaizen M. Bioavailability of metronidazole from sugar‐coated tablets in humans. II. Evaluation of beagle dogs as an animal model. Int. J. Pharm. 1985; 23: 289–298
   Google Scholar
• Lui C. Y., Amidon G. L., Berardi R. R., Fleisher D. Comparison of gastrointestinal pH in dogs and humans: implications on the use of the beagle dog as a model for oral absorption in humans. J. Pharm. Sci. 1986; 75(3)271–274
   PubMed Web of Science ®Google Scholar
• Hussein Z., Bialer M., Friedman M., Raz I. Comparative pharmacokinetic evaluation of sustained‐release theophylline formulations in dogs and humans. Int. J. Pharm. 1987; 37: 97–102
   Google Scholar
• Cook C. S., Hauswald C. L., Grahn A. Y., Kowalski K., Karim A., Koch R., Schoenhard G. L., Oppermann J. A. Suitability of the dog as an animal model for evaluating theophylline absorption and food effects from different formulations. Int. J. Pharm. 1990; 60: 125–132
   Web of Science ®Google Scholar
• Tse F. L.S., Szeto D. W. Theophylline bioavailability in the dog. J. Pharm. Sci. 1982; 71(11)1301–1303
   PubMedGoogle Scholar
• Glynn‐Barnhart A., Hill M., Szefler S. J. Sustained release theophylline preparations practical recommendations for prescribing and therapeutic drug monitoring. Drugs 1988; 35: 711–726
   PubMedGoogle Scholar
• Yu Z., Schwartz J. B., Sugita E. T. Theophylline controlled‐release formulations: in vivo‐in vitro correlations. Biopharm. Drug Dispos. 1996; 17: 259–272
   PubMed Web of Science ®Google Scholar
• Liaw J., Rubinstein A., Robinson J. R. Bioavailability study of theo‐dur tablets in the fasted cannulated dog. Int. J. Pharm. 1990; 59: 105–114
   Google Scholar
• Ishibashi T., Hatano H., Kobayashi M., Mizobe M., Yoshino H. In vivo drug release behavior in dogs from a new colon‐targeted delivery system. J. Control. Release 1999; 57: 45–53
   PubMed Web of Science ®Google Scholar
• Cox D. R. Planning of Experiments. John Wiley & Sons, Inc., New York 1992; 269–278
   Google Scholar
• McKiernan B. C., Neff‐Davis C. A., Koritz G. D., Davis L. E., Pheris D. R. Pharmacokinetic studies of theophylline in dogs. J. Vet. Pharmacol. Ther. 1981; 4: 103–110
   PubMedGoogle Scholar
• Wagner J. G. Pharmacokinetics for the Pharmaceutical Scientist. Technomic Publishing Company, Inc., Lancaster, PA 1993
   Google Scholar
• Gibaldi M. Biopharmaceutics and Clinical Pharmacokinetics4th Ed. Lea & Febiger, Malvern, PA 1991
   Google Scholar
• Bourne D. W.A. Mathematical Modeling of Pharmacokinetic Data. Technomic Publishing Company, Inc., Lancaster, PA 1995
   Google Scholar
• FDA. Guidance for Industry: Extended Release Oral Dosage Forms: Development, Evaluation, and Application of In Vitro/In Vivo Correlations. 1997
   Google Scholar
• Wagner J. G. L. Z. Benet, G. Levy, B. L. FerraioloUnusual pharmacokinetics. Pharmacokinetics—A Modern View, . Plenum Press, New York 1984; 173–188
   Google Scholar
• Hussein Z., Friedman M. Release and absorption characteristics of novel theophylline sustained‐release formulations: in vitro‐in vivo correlation. Pharm. Res. 1990; 7(11)1167–1171
   PubMedGoogle Scholar
• Kiriyama A., Sugahara M., Yoshikawa Y., Kiso Y., Takada K. The bioavailability of oral dosage forms of a new HIV‐1 protease inhibitor, KNI‐272, in beagle dogs. Biopharm. Drug Dispos. 1996; 17: 125–134
   PubMed Web of Science ®Google Scholar
• Yamada K., Furuya A., Akimoto M., Maki T., Suwa T., Ogata H. Evaluation of gastrointestinal transit controlled‐beagle dog as a suitable animal model for bioavailability testing of sustained‐release acetaminophen dosage form. Int. J. Pharm. 1995; 119: 1–10
   Web of Science ®Google Scholar
• Munday D. L., Fassihi A. R., Villiers C. D. Bioavailability study of a theophylline oral controlled release capsule containing film coated mini‐tablets in beagle dogs. Int. J. Pharm. 1991; 69: 123–127
   Web of Science ®Google Scholar
• Dressman J., Yamada K. P. G. Welling, F. L.S. Tse, S. DigheAnimal models for oral drug absorption. Pharmaceutical Bioequivalence, . Marcel Dekker, Inc., New York 1991; 235–266
   Google Scholar
• Woolson R. F. Statistical Methods for the Analysis of Biomedical Data. Wiley, New York 1987
   Google Scholar
• Levy G., Hollister L. E. Dissolution rate limited absorption in man. J. Pharm. Sci. 1965; 54(8)1121–1125
   PubMedGoogle Scholar
• Chien Y. W. Novel Drug Delivery Systems—Fundamentals, Developmental Concepts, Biomedical Assessments. Marcel Dekker, Inc., New York 1982
   Google Scholar
• Liu Y., Schwartz J. B., Schnaare R. L., Sugita E. T. A multi‐mechanistic drug release approach in a bead dosage form and in vitro/in vivo correlation, Submitted Manuscript in Pharmaceutical Development and Technology
   Google Scholar
• Shoemaker D. P., Garland C. W., Niblep J. W. The Experiments in Physical Chemistry6th Ed. WCB/McGraw‐Hill, New York 1996; 55–61
   Google Scholar
• Davis S. S. The design and evaluation of controlled release systems for the gastrointestinal tract. J. Control. Release 1985; 2: 27–38
   Google Scholar
• Rubinstein A., Li V. H.K., Gruber P., Robinson J. R. A. Yacobi, E. Halperin‐WalegaGastrointestinal‐physiological variables affecting the performance of oral sustained release dosage forms. Oral Sustained Release Formulations: Design and Evaluation1st Ed., . Peagamon Press, New York 1988; 183–193
   Google Scholar